Hyperphosphorylated TDP-43 Traps TRIM21 Into Inactive Complexes

Target: TARDBP, TRIM21 Composite Score: 0.487 Price: $0.49 Citation Quality: Pending neurodegeneration Status: proposed
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
✓ All Quality Gates Passed
Quality Report Card click to collapse
C
Composite: 0.487
Top 80% of 1166 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
C Mech. Plausibility 15% 0.42 Top 89%
C Evidence Strength 15% 0.48 Top 76%
C+ Novelty 12% 0.55 Top 88%
C Feasibility 12% 0.45 Top 71%
C+ Impact 12% 0.50 Top 83%
C Druggability 10% 0.40 Top 78%
C+ Safety Profile 8% 0.50 Top 59%
B Competition 6% 0.60 Top 64%
C+ Data Availability 5% 0.52 Top 66%
C Reproducibility 5% 0.45 Top 80%
Evidence
2 supporting | 3 opposing
Citation quality: 0%
Debates
1 session B+
Avg quality: 0.75
Convergence
0.00 F 30 related hypothesis share this target

From Analysis:

How do pathological stress granules in neurodegeneration escape TRIM21/autophagy-mediated clearance?

The study shows TRIM21 and autophagy receptors can eliminate both physiological and pathological SGs, yet persistent stress granules are hallmarks of ALS/FTD. The mechanisms by which disease-associated SGs evade this clearance system remain unclear but are critical for therapeutic targeting. Gap type: open_question Source paper: Stress granule homeostasis is modulated by TRIM21-mediated ubiquitination of G3BP1 and autophagy-dependent elimination of stress granules. (2023, Autophagy, PMID:36692217)

→ View full analysis & debate transcript

Hypotheses from Same Analysis (6)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

C9orf72 DPRs Impair Autophagy Receptor Docking on Stress Granules
Score: 0.717 | Target: C9orf72, p62/SQSTM1, OPTN
Differential Ubiquitin Chain Topology Creates 'Invisible' Surface on Pathological Stress Granules
Score: 0.682 | Target: TRIM21, G3BP1, OTUD1/OTUD7B
ALS-Linked OPTN/TBK1 Mutations Impair Phosphorylation Cascade Required for Pathological SG Recognition
Score: 0.648 | Target: OPTN, TBK1
FUS Mutations Alter Stress Granule Material Properties to Confer Autophagy Resistance
Score: 0.613 | Target: FUS
ALS-Associated G3BP1/2 Mutations Disrupt TRIM21 Binding Interfaces
Score: 0.585 | Target: G3BP1, G3BP2
Casein Kinase 2 (CK2)-Mediated Hyperphosphorylation of G3BP1 Blocks TRIM21 Access
Score: 0.440 | Target: G3BP1, CSNK2A1 (CK2)

→ View full analysis & all 7 hypotheses

Description

In ALS" class="entity-link entity-disease" title="disease: ALS">ALS/FTD, pathological TDP-43 undergoes hyperphosphorylation, truncation (p25/C-terminal fragments), and aggregation. These modified species act as 'sponges' that sequester TRIM21 into non-productive complexes, creating functional deficit of available TRIM21 for G3BP1 ubiquitination. This hypothesis was deprioritized by domain expert assessment due to unvalidated protein interaction, stoichiometric implausibility (TRIM21 is abundant), and compartmentalization issues. TRIM21 is primarily nuclear while TDP-43 aggregates are cytoplasmic. Revised confidence: 0.45.

No AI visual card yet

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.42 (15%) Evidence 0.48 (15%) Novelty 0.55 (12%) Feasibility 0.45 (12%) Impact 0.50 (12%) Druggability 0.40 (10%) Safety 0.50 (8%) Competition 0.60 (6%) Data Avail. 0.52 (5%) Reproducible 0.45 (5%) 0.487 composite
5 citations 5 with PMID Validation: 0% 2 supporting / 3 opposing
For (2)
No supporting evidence
No opposing evidence
(3) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
5
MECH 5CLIN 0GENE 0EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
TDP-43 pathology is hallmark of >95% of ALS and…SupportingMECH----PMID:18789269-
TDP-43 C-terminal fragments accumulate in stressed…SupportingMECH----PMID:29706650-
TRIM21-TDP-43 interaction predicted from databases…OpposingMECH----PMID:29154813-
Stoichiometric implausibility: TRIM21 is abundant …OpposingMECH----PMID:28990070-
TRIM21 primarily nuclear; TDP-43 aggregates cytopl…OpposingMECH----PMID:16988484-
Legacy Card View — expandable citation cards

Supporting Evidence 2

TDP-43 pathology is hallmark of >95% of ALS and ~50% of FTD cases
TDP-43 C-terminal fragments accumulate in stressed neurons

Opposing Evidence 3

TRIM21-TDP-43 interaction predicted from databases, not experimentally validated
Stoichiometric implausibility: TRIM21 is abundant (~100,000-500,000 molecules/cell), aggregates would need eno…
Stoichiometric implausibility: TRIM21 is abundant (~100,000-500,000 molecules/cell), aggregates would need enormous sequestration
TRIM21 primarily nuclear; TDP-43 aggregates cytoplasmic - direct colocalization not demonstrated
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-22 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Mechanistic Hypotheses: Pathological Stress Granule Evasion of TRIM21/Autophagy Clearance

Hypothesis 1: G3BP1/2 Mutations Disrupt TRIM21 Binding Interfaces

Title: ALS-associated mutations in G3BP1/2 directly impair TRIM21-mediated ubiquitination and autophagy receptor recruitment

Mechanism:
Disease-associated mutations in G3BP1 (e.g., R378C, R382C/H) identified in ALS and amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) spectrum disorders may disrupt the TRIM21 recognition motif or alter protein conformation to prevent ubiquitination. G3BP1/2 serve as maste

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Critical Evaluation of Pathological Stress Granule Evasion Hypotheses

Hypothesis 1: G3BP1/2 Mutations Disrupt TRIM21 Binding Interfaces

  • Binding site assumption unverified: The R378C/R382C mutations are located in G3BP1's RRM2 domain, yet the actual TRIM21 binding interface on G3BP1 has not been mapped. These mutations may not directly contact TRIM21—they could affect RNA binding or G3BP1 dimerization instead.
  • Precedent mismatch with established mechanisms: Mutations in glycine-arginine rich (RG) motifs typically enhance, not diminish, protein-protein inter
  • 🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

    Expert Feasibility Assessment: Pathological Stress Granule Evasion Mechanisms

    Preamble: Filtering the Hypothesis Space

    Of the seven hypotheses, five survive critical scrutiny with confidence scores ≥0.50. Two are deprioritized: H3 (TDP-43 sequestration of TRIM21) and H5 (CK2 hyperphosphorylation) fall below this threshold. H3 relies on unvalidated protein interactions and stoichiometric implausibility; H5 contradicts established literature showing CK2 phosphorylation promotes SG assembly rather than dissolution. The five surviving hypotheses are assessed below across druggabil

    Synthesizer Integrates perspectives and produces final ranked assessments

    {"ranked_hypotheses":[{"title":"C9orf72 DPRs Impair Autophagy Receptor Docking on Stress Granules","description":"Hexanucleotide repeat expansions in C9orf72 generate toxic dipeptide repeat proteins (poly-GR, poly-PR, poly-GA) that sterically occlude ubiquitin-binding domains of p62/SQSTM1 and OPTN, preventing autophagy receptor recruitment to ubiquitinated stress granules. This mechanism accounts for the most common genetic cause of familial ALS/FTD (~40% of familial ALS, ~25% of familial FTD) and may apply to downstream pathways shared with sporadic disease. Existing ASO clinical trials targ

    Price History

    0.480.490.50 0.51 0.47 2026-04-222026-04-222026-04-22 Market PriceScoreevidencedebate 1 events
    7d Trend
    Stable
    7d Momentum
    ▲ 0.0%
    Volatility
    Low
    0.0000
    Events (7d)
    1

    Clinical Trials (1)

    0
    Active
    0
    Completed
    0
    Total Enrolled
    Untitled Trial Unknown
    Unknown ·

    📚 Cited Papers (5)

    Paper:16988484
    No extracted figures yet
    Paper:18789269
    No extracted figures yet
    Paper:28990070
    No extracted figures yet
    Paper:29154813
    No extracted figures yet
    Paper:29706650
    No extracted figures yet

    📓 Linked Notebooks (0)

    No notebooks linked to this analysis yet. Notebooks are generated when Forge tools run analyses.

    ⚔ Arena Performance

    No arena matches recorded yet. Browse Arenas
    → Browse all arenas & tournaments

    Related Hypotheses

    TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration
    Score: 0.990 | neurodegeneration
    LRP1-Dependent Tau Uptake Disruption
    Score: 0.979 | neurodegeneration
    Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte Secretome
    Score: 0.975 | neurodegeneration
    TREM2-Dependent Microglial Senescence Transition
    Score: 0.950 | neurodegeneration
    PLCG2 Allosteric Modulation as a Precision Therapeutic for TREM2-Dependent Microglial Dysfunction
    Score: 0.941 | neurodegeneration

    Estimated Development

    Estimated Cost
    $0
    Timeline
    0 months

    🧪 Falsifiable Predictions

    No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

    Knowledge Subgraph (0 edges)

    No knowledge graph edges recorded

    3D Protein Structure

    🧬 TARDBP — PDB 4BS2 Click to expand 3D viewer

    Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

    Source Analysis

    How do pathological stress granules in neurodegeneration escape TRIM21/autophagy-mediated clearance?

    neurodegeneration | 2026-04-06 | archived

    Community Feedback

    0 0 upvotes · 0 downvotes
    💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

    No comments yet. Be the first to comment!

    View all feedback (JSON)